A world leader in cGMP manufacturing of Viral-Based Gene Therapy products About us More News & Events Contact Microkatu 1 S FI-70210 Kuopio , Finland +358 (0)17 240 875 info@finvector.com Contact Us Alert Channel News & Events Careers Privacy & Cookie Policy Etelä-Savo Centre for Economic Development, Transport and the Environment has granted FinVector Oy a total of EUR 6,555,000 for the construction of new pharmaceutical manufacturing facility. We use cookies to better the users experience while visiting the website. Click here to find out more Deny Allow

Home / News & Events / Our new GMP facility investment is progressing 19.11.2021 The investment of our 5th GMP faciltiy is progressing. We have received a permission from the city of Kuopio to deviate from the zoning plan for the area. Next we will apply for the building permit. "We are part of the Ferring Ventures Group, which has invested and helped us grow. In that sense, it looks good", says our director of procurement and logistics Mikko Kämäräinen. Read Yle's article in Finnish here. Contact Microkatu 1 S FI-70210 Kuopio , Finland +358 (0)17 240 875 info@finvector.com Contact Us Alert Channel News & Events Careers Privacy & Cookie Policy Etelä-Savo Centre for Economic Development, Transport and the Environment has granted FinVector Oy a total of EUR 6,555,000 for the construction of new pharmaceutical manufacturing facility. We use cookies to better the users experience while visiting the website. Click here to find out more Deny Allow